Mark D - Search Results

1

When innovative therapies make economic sense: economic analysis of enoxaparin versus unfractionated heparin in the ESSENCE trial--an overview. Efficacy and Safety of Subcutaneous in non-Q Wave Coronary Events.

Mark D. Mark D. Can J Cardiol. 1998 Aug;14 Suppl E:24E-27E. Can J Cardiol. 1998. PMID: 9779030 Clinical Trial.

2

Obesity and long-term clinical and economic outcomes in coronary artery disease patients.

Eisenstein EL, Shaw LK, Nelson CL, Anstrom KJ, Hakim Z, Mark DB. Eisenstein EL, et al. Obes Res. 2002 Feb;10(2):83-91. doi: 10.1038/oby.2002.14. Obes Res. 2002. PMID: 11836453 Free article.

3

Economic analysis of the Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT-3) study: costs of reperfusion strategies in acute myocardial infarction.

Kaul P, Armstrong PW, Cowper PA, Eisenstein EL, Granger CB, Van de Werf F, Mark DB. Kaul P, et al. Am Heart J. 2005 Apr;149(4):637-44. doi: 10.1016/j.ahj.2004.02.019. Am Heart J. 2005. PMID: 15990746

4

Association between bleeding, blood transfusion, and costs among patients with non-ST-segment elevation acute coronary syndromes.

Rao SV, Kaul PR, Liao L, Armstrong PW, Ohman EM, Granger CB, Califf RM, Harrington RA, Eisenstein EL, Mark DB. Rao SV, et al. Am Heart J. 2008 Feb;155(2):369-74. doi: 10.1016/j.ahj.2007.10.014. Epub 2007 Dec 19. Am Heart J. 2008. PMID: 18215610 Clinical Trial.

5

Long-term economic outcomes associated with intensive versus moderate lipid-lowering therapy in coronary artery disease: results from the Treating to New Targets (TNT) Trial.

Mark DB, Knight JD, Cowper PA, Davidson-Ray L, Anstrom KJ. Mark DB, et al. Am Heart J. 2008 Oct;156(4):698-705. doi: 10.1016/j.ahj.2008.05.032. Epub 2008 Sep 5. Am Heart J. 2008. PMID: 18926150 Clinical Trial.

6

Economic Outcomes With Anatomical Versus Functional Diagnostic Testing for Coronary Artery Disease.

Mark DB, Douglas PS, Daniels MR. Mark DB, et al. Ann Intern Med. 2016 Dec 20;165(12):891. doi: 10.7326/L16-0482. Ann Intern Med. 2016. PMID: 27992905 No abstract available.

7

Variability in cost of coronary bypass surgery in New York State: potential for cost savings.

Cowper PA, DeLong ER, Peterson ED, Hannan EL, Ray KT, Racz M, Mark DB. Cowper PA, et al. Among authors: mark db. Am Heart J. 2002 Jan;143(1):130-9. doi: 10.1067/mhj.2002.119617. Am Heart J. 2002. PMID: 11773923

8

Vasopeptidase inhibitor reduces inhospital costs for patients with congestive heart failure: results from the IMPRESS trial. Inhibition of Metallo Protease by BMS-186716 in a Randomized Exercise and Symptoms Study in Subjects With Heart Failure.

Eisenstein EL, Nelson CL, Simon TA, Smitten AL, Lapuerta P, Mark DB. Eisenstein EL, et al. Am Heart J. 2002 Jun;143(6):1112-7. doi: 10.1067/mhj.2002.123111. Am Heart J. 2002. PMID: 12075271 Clinical Trial.

9

Poverty, process of care, and outcome in acute coronary syndromes.

Rao SV, Kaul P, Newby LK, Lincoff AM, Hochman J, Harrington RA, Mark DB, Peterson ED. Rao SV, et al. Among authors: mark db. J Am Coll Cardiol. 2003 Jun 4;41(11):1948-54. doi: 10.1016/s0735-1097(03)00402-9. J Am Coll Cardiol. 2003. PMID: 12798563 Free article.

10

Effect of smoking and sedentary behavior on the association between depressive symptoms and mortality from coronary heart disease.

Brummett BH, Babyak MA, Siegler IC, Mark DB, Williams RB, Barefoot JC. Brummett BH, et al. Am J Cardiol. 2003 Sep 1;92(5):529-32. doi: 10.1016/s0002-9149(03)00719-7. Am J Cardiol. 2003. PMID: 12943871

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

962 results

Search Page

Filters